Status:
WITHDRAWN
Adolescent and Adult Subjects With Asthma and Seasonal Allergic Rhinitis Receiving Advair Diskus or Placebo
Lead Sponsor:
Creighton University
Collaborating Sponsors:
GlaxoSmithKline
Conditions:
Asthma
Seasonal Allergic Rhinitis
Eligibility:
All Genders
15-75 years
Phase:
NA
Brief Summary
The four respiratory drugs being researched in this study have been approved by the US Food and Drug Administration (FDA) and are currently available by prescription at your drug store. One of the dru...
Detailed Description
4-week study to assess asthma control as measured by lung function and clinical features, rhinitis treatment, subject-rated overall satisfaction with treatment, and safety outcomes when FLONASE™ 200mc...
Eligibility Criteria
Inclusion
- Signed and dated written informed consent is obtained.
- Male or female
- 15 Years and older
- Diagnosis of persistent asthma for at least three months.
- 3 months prior and current use of specified asthma therapies
- FEV1 between 65-95% of predicted value
- Diagnosis of seasonal allergic rhinitis
- Active residence within geographical regions where exposure to relevant seasonal allergic is expected
Exclusion
- Currently diagnosed with life-threatening asthma
- Asthma instability
- Concurrent respiratory disease
- Nasal obstruction
- Nasal history
- Certain concurrent conditions/diseases
- Drug allergy
- Respiratory tract infections
- Specific (listed in protocol) concurrent medications
- Systemic corticosteroids
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00385463
Start Date
April 1 2006
End Date
April 1 2007
Last Update
June 16 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Creighton University
Omaha, Nebraska, United States, 68131